EP.12A.29 Characteristics of Osimertinib Non-Responders vs Responders in EGFR Mutated Lung Cancer

Autor: Reyes, A., Sampath, S., Muddasani, R., Afkhami, M., Amini, A., Villaflor, V., Salgia, R., Rock, A., Li, X., Massarelli, E.
Zdroj: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S632-S632
Databáze: ScienceDirect